New Properties and Mitochondrial Targets of Polyphenol Agrimoniin as a Natural Anticancer and Preventive Agent

Tatiana A Fedotcheva1, Olga P Sheichenko2, Nadezhda I Fedotcheva3

  • 1Science Research Laboratory of Molecular Pharmacology, Medical Biological Faculty, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Ostrovityanova St. 1, Moscow 117997, Russia.

Pharmaceutics
|December 28, 2021
PubMed

Insights

Agrimoniin, a polyphenol from Agrimonia pilosa, directly impacts mitochondrial function. This compound can induce apoptosis by opening the mitochondrial permeability transition pore (MPTP), offering potential therapeutic benefits.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cell Biology

Background:

  • Agrimoniin, a polyphenol tannin, exhibits antioxidant and anticancer properties.
  • Its anticancer mechanism is hypothesized to involve mitochondria-dependent apoptosis, but specific targets remain unclear.

Purpose of the Study:

  • To investigate the direct effects of agrimoniin on mitochondrial functions.
  • To determine if agrimoniin induces apoptosis via the mitochondrial permeability transition pore (MPTP).

Main Methods:

  • Isolation and purification of agrimoniin from Agrimonia pilosa.
  • Cytotoxicity assessment using MTT assay on K562 and HeLa cancer cells.
  • Evaluation of isolated rat liver mitochondria function, including MPTP opening, respiration, and electron transport.

Main Results:

  • Agrimoniin (80% purity) demonstrated cytotoxic effects on cancer cell lines.
  • Low concentrations of agrimoniin induced mitochondrial swelling, inhibited by MPTP blockers.
  • Agrimoniin activated MPTP opening, stimulated succinate-supported respiration, reduced DCPIP, and chelated iron ions.

Conclusions:

  • Agrimoniin directly influences mitochondrial functions, including MPTP opening, suggesting a role in apoptosis induction.
  • These properties indicate agrimoniin's potential for stimulating apoptosis or enhancing mitochondrial function for therapeutic applications.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K